PharMerica CORP Restructuring and Related Cost, Incurred Cost
PharMerica CORP reported Restructuring and Related Cost, Incurred Cost of $2.90 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostIncurredCost · last filed 2017-02-24
- PharMerica CORP restructuring and related cost, incurred cost for fiscal 2016 was $2.90M, a 480.00% increase from fiscal 2015.
- PharMerica CORP restructuring and related cost, incurred cost for fiscal 2015 was $500.00K, a 84.85% decline from fiscal 2014.
- PharMerica CORP restructuring and related cost, incurred cost for fiscal 2014 was $3.30M.
| Period end | Restructuring and Related Cost, Incurred Cost 12 month |
|---|---|
| 2016-12-31 | $2.90M 10-K · filed 2017-02-24 |
| 2015-12-31 | $500.00K 10-K · filed 2017-02-24 |
| 2014-12-31 | $3.30M 10-K · filed 2017-02-24 |